Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Serve Robotics to Present at Cantor Global Technology Conference
-
AMD Unveils Next-Generation AMD RDNA™ 4 Architecture with the Launch of AMD Radeon™ RX 9000 Series Graphics Cards
-
Orderly Integrates Berachain to Enhance Access to Omnichain Liquidity
-
Fluent Announces Unaudited Fourth Quarter and Full-Year 2024 Financial Results
-
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
-
Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2024 and Declaration of Distributions on Common Stock for the Months Ending Apri
-
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
-
Daniella C. Vespoli Joins Calfee, Halter & Griswold Law Firm as Corporate and Finance Partner
-
MEDIA ALERT: Lancôme and Well+Good Present the Recovery Portal
-
Modern Aviation Partners with the City of Charlotte to Manage its FBO at Charlotte Douglas International Airport
-
SailPoint Announces Date of Fiscal Q4 and Full Year 2025 Earnings Conference Call
-
Alignment Healthcare to Present at the Leerink Global Healthcare Conference and KeyBanc Capital Markets Healthcare Forum
-
Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center
-
Nayax Announces the Acquisition of UPPay
-
Scatec completes sale of African hydropower assets to TotalEnergies for USD 167 million
-
Avance Gas Holding Ltd: Key information relating to extraordinary dividend of $0.75 per share
-
Banco Santander Chile Announces the Filing of Its Annual Report on Form 20-F With the United States Securities and Exchange Commission for Fiscal Year 2024
-
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
-
Avance Gas Holding Ltd: Closing of the sale of the MGC fleet and extraordinary dividend of $0.75 per share
-
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
-
AGF Investments Launches AGF Enhanced U.S. Income Plus Fund
-
Compass Lexecon Enhances Capabilities with Appointment of Prominent Economist Ginger Jin
-
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
-
AGM Group Holdings Inc. Announces Strategic Partnership with HashBeaver to Drive Blockchain and AI Innovation
-
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C
-
Emerging Markets Report: Crystal Balls, Clarity & Confidence
-
Emerging Markets Report: Crystal Balls, Clarity & Confidence
-
2025 Financial Calendar
-
Completion of conversion of A shares to B shares in accordance with the articles of association and information on adjusted number of voting rights and share capital
-
AGF Investments Announces Proposed Fund and ETF Terminations
-
Boralex Launches Normal Course Issuer Bid
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
-
Appian To Participate in Upcoming Investor Conferences
-
Cheems Memecoin Surpasses 80,000 Holders, Solidifying Its Place as a Leading Meme Token on BNB Chain
-
Anne De Greef-Safft joins Brady Corporation Board of Directors
-
Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
-
Boralex reports net earnings of $74 million for fiscal 2024 and continues construction of its large-scale projects in Québec, Ontario and the United Kingdom
-
Opthea Reports Half Year Results and Business Updates
-
BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
-
Fairfax Announces Intention to Redeem Cumulative Preferred Shares, Series E, F & M
-
Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration
-
Abacus Announces Financing
-
Xali Gold Enters Option to Acquire Sarape Project Located Within Rio Sonora Valley, Mexico
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
LiveOne (Nasdaq: LVO) Surpasses 1 Million Subscribers, Including Tesla
-
TeraWulf Reports Fourth Quarter and Full Year 2024 Results
-
Plug Power Adopts Executive Compensation Program to Strengthen Leadership Alignment with Shareholders
-
NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market
-
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

